Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-25

Clinical Trial Update: Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS) [NA]

View source ↗

Summary

The LEAP lifestyle program for irritable bowel syndrome is an ongoing clinical trial sponsored by Oxford Biomedical Technologies and is currently not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oxford Biomedical Technologies, Inc. | Conditions: IBS - Irritable Bowel Syndrome | NA | Status: ACTIVE_NOT_RECRUITING